Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381377953> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W4381377953 abstract "Insulin titration inertia is a key barrier to optimal glycemic control, particularly in areas where diabetes is highly prevalent and specialized healthcare professionals (HCP) are limited. MDC is a US FDA-approved digital smartphone application designed to help PWT2D to titrate BI according to HCP-prescribed individualized titration plan. This real-world analysis evaluated clinical outcomes in PWT2D in Saudi Arabia (SA) and Kuwait who were on BI therapy, registered on MDC from 05/01/2021 to 08/31/2022, and recorded ≥2 FBG readings in the app over a 2-week period. FBG target achievement, change in FBG, and hypoglycemia were assessed. A total of 197 MDC users with mean (SD) age of 51.5 (14.4) years were included (Table). Overall, 116 (58.9%) users achieved their individualized FBG target, 14 (7.1%) were still titrating and 67 (34.0%) stopped using MDC. The mean (SD) time to reach FBG target was 16.3 (20.8) days. Mean (SD) FBG decreased from 172.4 (75.7) mg/dL at baseline to 136.5 (54.3) mg/dL and BI dose increased from 21.9 (16.8) U to 25.1 (16.2) U. Moreover, high usage of MDC app was associated with a greater reduction in FBG versus moderate or low usage. Overall, hypoglycemia events were reported in 7 (3.6%) participants. PWT2D from SA and Kuwait were able to successfully utilize MDC app to titrate their BI doses and achieve FBG target with low risk of hypoglycemia Disclosure M. Al-sofiani: Consultant; Eli Lilly and Company, Speaker's Bureau; Sanofi, Medtronic, Vitalair. M. Almehthel: None. E. S. Alozairi: None. J. Sadik: Employee; Sanofi. L. Hao: Employee; Sanofi. Y. Akil: Employee; Sanofi. Funding Sanofi" @default.
- W4381377953 created "2023-06-21" @default.
- W4381377953 creator A5007706755 @default.
- W4381377953 creator A5027114136 @default.
- W4381377953 creator A5036368764 @default.
- W4381377953 creator A5052931457 @default.
- W4381377953 creator A5059924038 @default.
- W4381377953 creator A5062433808 @default.
- W4381377953 date "2023-06-20" @default.
- W4381377953 modified "2023-09-27" @default.
- W4381377953 title "132-LB: Real-World Effectiveness of My Dose Coach (MDC)-Assisted Basal Insulin (BI) Titration in People with Type 2 Diabetes (PWT2D) in Saudi Arabia and Kuwait" @default.
- W4381377953 doi "https://doi.org/10.2337/db23-132-lb" @default.
- W4381377953 hasPublicationYear "2023" @default.
- W4381377953 type Work @default.
- W4381377953 citedByCount "0" @default.
- W4381377953 crossrefType "journal-article" @default.
- W4381377953 hasAuthorship W4381377953A5007706755 @default.
- W4381377953 hasAuthorship W4381377953A5027114136 @default.
- W4381377953 hasAuthorship W4381377953A5036368764 @default.
- W4381377953 hasAuthorship W4381377953A5052931457 @default.
- W4381377953 hasAuthorship W4381377953A5059924038 @default.
- W4381377953 hasAuthorship W4381377953A5062433808 @default.
- W4381377953 hasConcept C126322002 @default.
- W4381377953 hasConcept C134018914 @default.
- W4381377953 hasConcept C2777180221 @default.
- W4381377953 hasConcept C2778024521 @default.
- W4381377953 hasConcept C2779306644 @default.
- W4381377953 hasConcept C2780473172 @default.
- W4381377953 hasConcept C2780668416 @default.
- W4381377953 hasConcept C2909524832 @default.
- W4381377953 hasConcept C555293320 @default.
- W4381377953 hasConcept C71924100 @default.
- W4381377953 hasConceptScore W4381377953C126322002 @default.
- W4381377953 hasConceptScore W4381377953C134018914 @default.
- W4381377953 hasConceptScore W4381377953C2777180221 @default.
- W4381377953 hasConceptScore W4381377953C2778024521 @default.
- W4381377953 hasConceptScore W4381377953C2779306644 @default.
- W4381377953 hasConceptScore W4381377953C2780473172 @default.
- W4381377953 hasConceptScore W4381377953C2780668416 @default.
- W4381377953 hasConceptScore W4381377953C2909524832 @default.
- W4381377953 hasConceptScore W4381377953C555293320 @default.
- W4381377953 hasConceptScore W4381377953C71924100 @default.
- W4381377953 hasIssue "Supplement_1" @default.
- W4381377953 hasLocation W43813779531 @default.
- W4381377953 hasOpenAccess W4381377953 @default.
- W4381377953 hasPrimaryLocation W43813779531 @default.
- W4381377953 hasRelatedWork W1968873653 @default.
- W4381377953 hasRelatedWork W1979382511 @default.
- W4381377953 hasRelatedWork W1997841581 @default.
- W4381377953 hasRelatedWork W2032907705 @default.
- W4381377953 hasRelatedWork W2051808761 @default.
- W4381377953 hasRelatedWork W2067861201 @default.
- W4381377953 hasRelatedWork W2795301291 @default.
- W4381377953 hasRelatedWork W3045858337 @default.
- W4381377953 hasRelatedWork W3164459101 @default.
- W4381377953 hasRelatedWork W3210022710 @default.
- W4381377953 hasVolume "72" @default.
- W4381377953 isParatext "false" @default.
- W4381377953 isRetracted "false" @default.
- W4381377953 workType "article" @default.